MedPath

Is Papaya leaf extract useful in treating Dengue patients?

Phase 2
Conditions
Health Condition 1: null- Patients with dengue fever
Registration Number
CTRI/2017/07/009139
Lead Sponsor
Bangalore Baptist Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Inclusion criteria

a. Age 15-70 years and

b. Dengue Ag/Ab OR both Ag, Ab positive

c. Inpatients

d. Platelet count less than 1,00,000 and

e. Patients willing to participate in study and given informed consent

Exclusion Criteria

•Pregnant or lactating women

•Patients with Dengue hemorrhagic fever grade III and IV,

•Patients with platelet count less than 10000/micro liter

•Patients with thrombocytopenia presenting with active bleeding

•Patients who have received blood or blood products transfusion during the current illness or during past one week,

•Patients with thrombocytopenia Purpura (ITP), Leukemia, Hemophilia or bleeding diathesis

•Patients with history of papaya leaf extract consumption prior to admission.

•Participation in another trial with another investigational drug within 1 month prior to informed consent.

•The presence of any other condition that leads the investigator to conclude that the patient is inappropriate for inclusion in the clinical study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath